Search results for PX-TA1017

Dulaglutide Biosimilar – Anti-Glucagon-like peptide-1 receptor agonist mAb – Research Grade, ProteoGenix, PX-TA1017

Description of Dulaglutide Biosimilar - Anti-Glucagon-like peptide-1 receptor agonist mAb - Research Grade General information about Dulaglutide Dulaglutide is a novel glucagon-like peptide-1 agonist (GLP-1) biologic drug consisting of a dipeptidyl peptidase-IV-protected GLP-1 analogue covalently linked to a human IgG4-Fc heavy chain by a small peptide linker. Dulaglutide is indicated in the treatment of type 2 diabetes and can be used once a week. This product is for research use only.